News

Treating coma aberration

Here, Dr Cadarso discusses how he targets vertical coma specifically through adaptation of the Keraring ICRS implantation technique.

In this article, the authors report on a case of two brothers with genetically proved Leber's disease associated with the rarer mutation G3635A, which is the only family case encountered in Bulgaria thus far.

Nocturnal IOP

Nocturnal IOP measurements are critical in evaluating drugs, according to Professor Cordeiro speaking at the 4th World Congress on Controversies in Ophthalmology.

According to this article, not all patients may benefit from routine testing prior to surgery. A better option may be selective screening for those at greatest risk for adverse systemic events.

In this article, Dr Akpek discusses the pros and cons of currently available options in the management of meibomian gland dysfunction.

Post-refractive surgery dry eye is an unwanted yet reoccurring problem for surgeons, according to Dr Cummings. In this article, he discusses the pre-op approach taken in his practice, which leads to a more certain diagnosis and higher patient satisfaction rates.

Various issues impact the effectiveness of population screening for open-angle glaucoma (OAG). However, use of ethnicity-specific normative databases for structural tests may improve their diagnostic performance, said Dr Mingguang He, PhD.

The European Academy of Optometry and Optics (EAOO) has launched its first 3-year strategic plan for 2014 through 2016.

Retinal injury following childhood exposure to laser 'toys' is a public safety concern, according to the first case series of such injuries, which has recently been published.

Premature infants with very low birth weight who receive an intravenous fat emulsion containing fish oil are less likely to develop retinopathy of prematurity (ROP), according to a recent study.

IOP measurements obtained with the rebound tonometer (Icare Pro) are more comparable to those achieved with the Goldmann applanation tonometer than those obtained with ultra-high-speed Scheimpflug technology, according to a recent study.

A novel, patented multi-component IOL (IVO Lens, InfinitVision Optics) allows for postoperative adjustments for changes in refraction, making it an ideal solution for paediatric cataract surgery, according to a recent report.

The combination of sutureless coaxial microincision cataract surgery and 23-gauge vitrectomy confers many advantages, including less wound leakage, good anterior chamber stability, safety, decreased inflammation and faster rehabilitation after surgery, according to the authors of a study published recently in Retina: The Journal of Retinal and Vitreous Diseases.

Patients who develop advanced age-related macular degeneration (AMD) undergo a precipitous loss of vision, concluded the researchers of this study recently published in the Journal of the American Medical Association Ophthalmology.

Patients with optic disc swelling caused by nonarteritic anterior ischaemic optic neuropathy (NAION) have less light retardance compared with patients with optic disc swelling caused by papilloedema or optic neuritis.

Collagen crosslinking (CXL) in patients with progressive keratoconus was found to be effective after 2 years in improving uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), topographic metrics, and most corneal higher-order aberrations, according to a study published in Cornea: The Journal of Cornea and External Disease. Researchers noted that there was a significant reduction in apical keratometry, which directly correlated with improvements in visual acuity

Autologous serum (AS) eye drops on the ocular surface of patients with bilateral severe dry eye improved not only ocular surface dryness, but decreased damage of the epithelium as well, as measured by clinical, laboratory, and subjective criteria, according to results from a study recently published in Current Eye Research

Steroid-induced central serous chorioretinopathy (CSC) may only occur in select patients who are vulnerable, rather than having a dose-dependent effect, according to a recent study published in Investigative Ophthalmology & Visual Science

Patients with pseudophakic eye who have undergone cataract will have greater access to fluocinolone acetonide (Iluvien, Alimera Sciences) for the treatment of chronic diabetic macular oedema (DME) that is considered refractive to available therapies. The National Institute for Health and Care Excellence (NICE) has published a final guidance recommending fluocinolone acetonide, making it available for patients through the National Health Service (NHS).

All anti-vascular endothelial growth factor (VEGF) agents improve visual acuity compared with laser photocoagulation, but there is insufficient evidence to distinguish the performance of any single anti-VEGF agent over another, according to results from a recently-conducted meta-analysis from researchers at the Institute for Clinical and Economic Review. The safety of bevacizumab also remains uncertain.

Despite treatment, chloroquine retinopathy may continue to progress long after drug cessation, according to a study published on-line by the British Journal of Ophthalmology. Further, disease progression may be accompanied by cystoid macular oedema, epiretinal membrane formation and peripheral involvement.

Small incision lenticule extraction (SMILE) caused less keratocyte apoptosis, proliferation and inflammation compared with femtosecond laser LASIK, according to data from a recent animal model study.

The Home Monitoring of the Eye (HOME) study, conducted in AREDS2 clinical centres, has demonstrated that patients at high-risk of developing choroidal neovascularization (CNV) - the neovascular or wet phase of AMD - benefit from using the ForeseeHome monitoring device (Notal Vision).

According to recently published data, anti-VEGF therapy is superior to laser photocoagulation for the treatment of moderate-to-severe visual impairment caused by diabetic macular oedema (DME).

Roche has announced additional encouraging results of a phase II study with lampalizumab to treat patients with geographic atrophy (GA). The MAHALO study data was presented during the Retina subspeciality day at AAO 2013 in New Orleans, Louisiana, USA.